Chief Access Officer
Hema leads our Health Markets Team. The team sources and develops pipeline opportunities for the deployment of MedAccess’ tools, manages monitoring and implementation of transactions post-execution, and analyses development impact throughout the partnership development and implementation process.
Hema leads our work to identify opportunities for financial tools to support lower prices and greater availability for medical products.
Hema joined MedAccess from Gilead Sciences, where she was Senior Director for South Asia. She previously served as Associate Director of the Global Markets Team at the Clinton Health Access Initiative where she developed global market shaping strategies and led negotiations to increase access to life-saving medical products.
Earlier in her career, Hema worked in Equity Research covering the Biotechnology and Healthcare Services sectors at Goldman Sachs and at Morgan Stanley.
Email Hema: [email protected]